Aristo Bio-Tech and Lifescience share news, announcements and annual reports

NSE: ARISTOFertilizers & Agrochemicals

Aristo Bio-Tech and Lifescience Limited · Face value ₹10 · Listed Jan 2023 · Issue price ₹72

₹86.00₹0.00 (0.00%)

Share price at the NSE close on 30 Oct 2026. Previous close ₹86.00.

30 Oct: open ₹86.00, high ₹86.00, low ₹86.00

52-week range of traded prices to 30 Oct 2026

₹74.30Low, 2 Apr 2026₹135.00High, 3 Nov 2025

Market cap: ₹59 Cr
P/E: 8.15
P/B: 1.32
Dividend yield: 0.70%
ROE: 17.6%
Debt to equity: 0.80
Volume, NSE: 3,200100.0% delivered

Aristo Bio-Tech and Lifescience board meetings

24 filed, newest first.

Sep 2026
- 7 Sep · Board meeting
  Outcome of Board Meeting held on September 07, 2026.
May 2026
- 28 May · Board meeting
  Board meeting to be held on May 29, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 30, 2026, To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters.
- 21 May · Board meeting
  To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
  Not held on this date
Feb 2026
- 26 Feb · Board meeting
  Outcome of Board Meeting held on February 26, 2026.
Nov 2025
- 8 Nov · Board meeting
  To consider and approve the financial results for the period ended September 30, 2025 and other business matters.
Aug 2025
- 22 Aug · Board meeting
  Board meeting held on August 22, 2025.
- 14 Aug · Board meeting
  Board meeting held on August 14, 2025.
May 2025
- 23 May · Board meeting
  To consider and approve the financial results for the period ended March 31, 2025, dividend and other business matters
Mar 2025
- 10 Mar · Board meeting
  Board meeting held on March 10, 2025.
Nov 2024
- 14 Nov · Board meeting
  Board meeting held on November 14, 2024.
- 13 Nov · Board meeting
  Board meeting to be held on November 13, 2024 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on November 14, 2024, To consider and approve the financial results for the period ended September 30, 2024 and other business matters
- 8 Nov · Board meeting
  To consider and approve the financial results for the period ended September 30, 2024 and other business matters
  Not held on this date
Aug 2024
- 28 Aug · Board meeting
  Board meeting held on August 28, 2024.
May 2024
- 27 May · Board meeting
  Board meeting held on May 27, 2024.
- 21 May · Board meeting
  To consider and approve the financial results for the period ended March 31, 2024, dividend and other business matters
Mar 2024
- 19 Mar · Board meeting
  Sub: Outcome of board meeting held on today i.e. on, March 19, 2024, in terms of second proviso to Regulation 30(6) Of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Ref: Aristo Bio-Tech and Lifescience Limited (Symbol: - ARISTO, ISIN: - INE082101010)With reference to captioned subject, we hereby inform you that the Board of Directors of the Company, in their Board Meeting held on today, i.e. on Tuesday, March 19, 2024, at the Registered Office of the Company situated at E-24,25,26, G.I.D.C., Ta. Savli, Manjusar, Vadodara-391775, Gujarat, which was commenced at 05:30 P.M. and concluded at 06:15 P.M.;1. On recommendation of Nomination & Remuneration Committee, appointed Mrs. Ayushi Deora (Membership No. 70433) as Company Secretary & Compliance Officer of the Company w.e.f. March 19, 2024. The details as required under Regulation 30 read with Schedule III of The SEBI (LODR) Regulations,2015 and in terms of SEBI Circular no. SEBI/HO/CFD/CFD-PoD1/P/CIR/2023/123 dated July 13, 2023 is given in the enclosed Annexure I.2. Authorization to Key Managerial Personnel under Regulation 30 (5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.Pursuant to regulation 30(5) of the SEBI (Listing Obligation and Disclosure Requirement Regulations) 2015, the Board of Directors of the Company has, at its Board meeting held on October 09, 2023 has authorised below mentioned Key Managerial Personnel for the purpose of determining the Materiality of events or information for the purpose of making disclosure to the Stock Exchange:Sr. No. Name of Personnel Designation Contact Details1. Narendra Singh Barhat Chairman & Managing Director Email : mail@aristobiotech.comPh. No.: +91 (2667) 264841/ 2648432. Ketankumar Harkantbhai Joshi Whole time Director 3. Company Secretary & Compliance officer 3. Considered and approved all other business as per agenda circulated.
Nov 2023
- 7 Nov · Board meeting
  Outcome of Board Meeting held today i.e. on November 07, 2023 in terms of second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.Ref: Aristo Bio-Tech and Lifescience Limited (Symbol: - ARISTO, ISIN: - INE082101010)In reference to captioned subject, we hereby inform you that the Board of Directors of the Company, in their Board Meeting held today, i.e. on Tuesday, November 07, 2023, at the Registered Office of the Company situated at at E-24,25,26, G.I.D.C. Manjusar, Ta. Savli, Vadodara-391775, Gujarat, India which was commenced at 5:00 P.M. and concluded at 5:45 P.M., to have:1. Considered, approved and taken on record the Unaudited financial result of the Company for the Half year ended on September 30, 2023, and2. Statement of Assets and Liabilities.3. Cash Flow Statement.4. Approved the Limited Review Report issued by Statutory Auditors of the Company for the Half year ended on September 30, 2023,5. Took Note of the Resignation of Mr. Dipakkumar Harkant Joshi (DIN: 08549339), Non-Executive Director of the company due to personal reasons and personal commitment, with effect from close of business hours of November 07, 2023.6. Appointed M/s. SCS AND CO. LLP, Practicing Company Secretary, Ahmedabad as Secretarial Auditor for Secretarial Audit of the Company for the F.Y. 2023-247. Considered and approved all other business as per agenda circulated.Further, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we are enclosing herewith the Unaudited Financial Results for the Half year ended September 30, 2023 and Limited Review Report issued by Statutory Auditors on the Unaudited Financial results for the half year ended September 30, 2023.Resignation Letter received from Mr. Dipakkumar Harkant Joshi (DIN: 08549339) is enclosed herewith. Brief Profile of SCS AND CO. LLP, Practicing Company Secretary are also enclosed herewithFurther, Details as required under regulation 30 of listing regulations read with SEBI circular SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 are provided herewith.
Oct 2023
- 31 Oct · Board meeting
  Intimation of Board meeting for consideration of Unaudited Financial Results of the Company for the Half year ended on September 30, 2023.
- 9 Oct · Board meeting
  Board meeting held on October 09, 2023.
Aug 2023
- 28 Aug · Board meeting
  Board meeting held on August 28, 2023.
Jun 2023
- 20 Jun · Board meeting
  Board meeting held on Jun 20, 2023.
May 2023
- 27 May · Board meeting
  Board meeting held on May 27, 2023 Pursuant to the Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company, in their board Meeting held on today, i.e. Saturday, May 27,2023, at the registered office of the company situated at E-24,25,26, G.I.D.C., Ta. Savli, Manjusar, Vadodara-391775, Gujarat and which was commenced at 04.30 pm and concluded at 06.00 pm has inter-alia considered and approved the followings; 1. Considered, approved and taken on record the Audited financial results of the company for the half year and year ended on March 31, 2023 along with Audit Report (Unmodified Opinion) and Declaration by the Company for the Audit Report with Unmodified Opinion;2. Considered, approved and taken on record the audited Financial Statement of the Company, prepared pursuant to the Companies Act,2013 for the financial year ended on March 31, 2023.3. Recommended a Final Dividend of Rs. 0.25/ - (Twenty Five Paisa) per equity share, face value Rs. 10/ - per equity share (i.e. 2.5 % of face value) for the financial year ended on March 31, 2023, subject to approval of the members at the ensuing Annual General Meeting. Final Dividend, if approved by the members, will be paid/ dispatched after the Annual General Meeting.This intimation shall also be considered to be disclosure under clause 4(a) of Para A of part A of schedule III of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.4. Considered & approved all other business as per Agenda circulated.
- 20 May · Board meeting
  Board Meeting to be held on 27 May 2023 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2023 and Dividend/Other business.
Feb 2023
- 6 Feb · Board meeting
  Board meeting held on February 06, 2023. With reference to the above captioned subject, and pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the company in their meeting held today i.e. on Monday, February 06, 2023 at the registered office of the Company situated at E-24,25,26, G.I.D.C., Ta. Savli, Manjusar, Vadodara-391775, Gujarat which was commenced at 04:30 P.M. and concluded at 05:30 P.M., have considered and approved the following:1. Appointed M/s. SCS and Co. LLP, Practicing Company Secretary, Ahmedabad as Secretarial Auditor for Secretarial Audit of the Company for the F.Y. 2022-23.2. Authorised various Key Managerial Personnel for the purpose of determining the Materiality of events or information for the purpose of making disclosure to the Stock Exchange.3. Considered and approved all other business as per agenda circulated.

Aristo Bio-Tech and Lifescience board meetings

Sep 2026

May 2026

Feb 2026

Nov 2025

Aug 2025

May 2025

Mar 2025

Nov 2024

Aug 2024

May 2024

Mar 2024

Nov 2023

Oct 2023

Aug 2023

Jun 2023

May 2023

Feb 2023